A strategic approach to managing Immune Effector Cell-Associated Hematotoxicity (ICAHT) during chimeric antigen receptor T-cell therapy
Blood Research · 2026-12 · 61 (1)
DOI: 10.1007/s44313-026-00143-4 ↗Kurz gefasst
Leserbrief in der Zeitschrift Blood Research, online erschienen am 19.05.2026. Verfasst von Sang Eun Yoon. Beteiligte Einrichtung: Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro Gangnam-Gu, …. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro Gangnam-Gu, Seoul, 06351, Republic of Korea. starload0326@gmail.com.
Zitieren
APA
Yoon, S. E. (2026). A strategic approach to managing Immune Effector Cell-Associated Hematotoxicity (ICAHT) during chimeric antigen receptor T-cell therapy. Blood Research, 61(1). https://doi.org/10.1007/s44313-026-00143-4
Vancouver
Yoon SE. A strategic approach to managing Immune Effector Cell-Associated Hematotoxicity (ICAHT) during chimeric antigen receptor T-cell therapy. Blood Research. 2026;61(1). doi:10.1007/s44313-026-00143-4
BibTeX
@article{Yoon2026,
author = {Yoon, Sang Eun},
title = {A strategic approach to managing Immune Effector Cell-Associated Hematotoxicity (ICAHT) during chimeric antigen receptor T-cell therapy},
journal = {Blood Research},
year = {2026},
volume = {61},
number = {1},
doi = {10.1007/s44313-026-00143-4}
}
EUVIMED